Connection

Peter Kalivas to Dopamine

Back to Details
This is a "connection" page, showing publications Peter Kalivas has written about Dopamine.
Peter Kalivas
Connection Strength
7.203
Dopamine
  1. Cocaine activates Homer1 immediate early gene transcription in the mesocorticolimbic circuit: differential regulation by dopamine and glutamate signaling. Synapse. 2009 Jan; 63(1):42-53.
    View in: PubMed
    Score: 0.265
  2. Chronic ethanol consumption by C57BL/6 mice promotes tolerance to its interoceptive cues and increases extracellular dopamine, an effect blocked by naltrexone. Alcohol Clin Exp Res. 2003 Dec; 27(12):1892-900.
    View in: PubMed
    Score: 0.186
  3. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl). 2000 Aug; 151(2-3):99-120.
    View in: PubMed
    Score: 0.148
  4. The regulation of dopamine transmission by metabotropic glutamate receptors. J Pharmacol Exp Ther. 1999 Apr; 289(1):412-6.
    View in: PubMed
    Score: 0.135
  5. Glutamatergic and dopaminergic afferents to the prefrontal cortex regulate spatial working memory in rats. Neuroscience. 1999; 92(1):97-106.
    View in: PubMed
    Score: 0.132
  6. Dopamine depletion reorganizes projections from the nucleus accumbens and ventral pallidum that mediate opioid-induced motor activity. J Neurosci. 1998 Oct 01; 18(19):8074-85.
    View in: PubMed
    Score: 0.130
  7. The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission. Psychopharmacology (Berl). 1997 Sep; 133(2):188-95.
    View in: PubMed
    Score: 0.121
  8. Dopamine regulation of extracellular glutamate in the nucleus accumbens. Brain Res. 1997 Jun 27; 761(1):173-7.
    View in: PubMed
    Score: 0.119
  9. Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J Neurosci. 1997 May 01; 17(9):3254-61.
    View in: PubMed
    Score: 0.118
  10. The good and bad news about glutamate in drug addiction. J Psychopharmacol. 2016 11; 30(11):1095-1098.
    View in: PubMed
    Score: 0.111
  11. Sensitization to stress and psychostimulants. Involvement of dopamine transmission versus the HPA axis. Ann N Y Acad Sci. 1995 Dec 29; 771:617-25.
    View in: PubMed
    Score: 0.108
  12. Amphetamine produces sensitized increases in locomotion and extracellular dopamine preferentially in the nucleus accumbens shell of rats administered repeated cocaine. J Pharmacol Exp Ther. 1995 Nov; 275(2):1019-29.
    View in: PubMed
    Score: 0.106
  13. Dopamine depletion augments endogenous opioid-induced locomotion in the nucleus accumbens using both mu 1 and delta opioid receptors. Psychopharmacology (Berl). 1995 Aug; 120(3):347-55.
    View in: PubMed
    Score: 0.104
  14. Selective activation of dopamine transmission in the shell of the nucleus accumbens by stress. Brain Res. 1995 Mar 27; 675(1-2):325-8.
    View in: PubMed
    Score: 0.102
  15. Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend. 1995 Feb; 37(2):95-100.
    View in: PubMed
    Score: 0.101
  16. The relationship between MRNA levels and the locomotor response to novelty. Brain Res. 1994 Nov 14; 663(2):312-6.
    View in: PubMed
    Score: 0.099
  17. Individual locomotor response to novelty predicts selective alterations in D1 and D2 receptors and mRNAs. J Neurosci. 1994 Oct; 14(10):6144-52.
    View in: PubMed
    Score: 0.099
  18. Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo. Neuroscience. 1994 Sep; 62(1):41-50.
    View in: PubMed
    Score: 0.098
  19. Involvement of dopamine and excitatory amino acid transmission in novelty-induced motor activity. J Pharmacol Exp Ther. 1994 Jun; 269(3):976-88.
    View in: PubMed
    Score: 0.096
  20. Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex. Neuroscience. 1993 Apr; 53(3):695-703.
    View in: PubMed
    Score: 0.089
  21. Cross-sensitization between cocaine and acute restraint stress is associated with sensitized dopamine but not glutamate release in the nucleus accumbens. Eur J Neurosci. 2013 Mar; 37(6):982-95.
    View in: PubMed
    Score: 0.088
  22. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Brain Res Rev. 1993 Jan-Apr; 18(1):75-113.
    View in: PubMed
    Score: 0.087
  23. Time course of extracellular dopamine and behavioral sensitization to cocaine. II. Dopamine perikarya. J Neurosci. 1993 Jan; 13(1):276-84.
    View in: PubMed
    Score: 0.087
  24. Time course of extracellular dopamine and behavioral sensitization to cocaine. I. Dopamine axon terminals. J Neurosci. 1993 Jan; 13(1):266-75.
    View in: PubMed
    Score: 0.087
  25. Regulation of somatodendritic dopamine release in the ventral tegmental area by opioids and GABA: an in vivo microdialysis study. J Neurosci. 1992 Jul; 12(7):2623-32.
    View in: PubMed
    Score: 0.084
  26. Dopamine depletion produces augmented behavioral responses to a mu-, but not a delta-opioid receptor agonist in the nucleus accumbens: lack of a role for receptor upregulation. Synapse. 1992 May; 11(1):47-57.
    View in: PubMed
    Score: 0.083
  27. Microinjection of the D2 agonist quinpirole into the A10 dopamine region blocks amphetamine-, but not cocaine-stimulated motor activity. J Pharmacol Exp Ther. 1992 May; 261(2):811-8.
    View in: PubMed
    Score: 0.083
  28. Pertussis toxin in the A10 region increases dopamine synthesis and metabolism. J Neurochem. 1992 Mar; 58(3):811-6.
    View in: PubMed
    Score: 0.082
  29. Dopamine and endogenous opioid regulation of picrotoxin-induced locomotion in the ventral pallidum after dopamine depletion in the nucleus accumbens. Psychopharmacology (Berl). 1992; 108(1-2):141-6.
    View in: PubMed
    Score: 0.082
  30. In vivo assessment of release and metabolism of dopamine in the ventrolateral striatum of awake rats following administration of dopamine D1 and D2 receptor agonists and antagonists. Neuropharmacology. 1991 Dec; 30(12A):1269-74.
    View in: PubMed
    Score: 0.081
  31. Sensitization to psychostimulants and stress after injection of pertussis toxin into the A10 dopamine region. J Pharmacol Exp Ther. 1991 Nov; 259(2):916-24.
    View in: PubMed
    Score: 0.081
  32. Effects of cocaine and footshock stress on extracellular dopamine levels in the ventral striatum. Brain Res. 1991 Sep 13; 559(1):29-36.
    View in: PubMed
    Score: 0.080
  33. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Brain Res Rev. 1991 Sep-Dec; 16(3):223-44.
    View in: PubMed
    Score: 0.080
  34. Possible role for G-proteins in behavioral sensitization to cocaine. Brain Res. 1991 Apr 05; 545(1-2):287-91.
    View in: PubMed
    Score: 0.077
  35. A comparison of axonal and somatodendritic dopamine release using in vivo dialysis. J Neurochem. 1991 Mar; 56(3):961-7.
    View in: PubMed
    Score: 0.077
  36. Dopaminergic involvement in locomotion elicited from the ventral pallidum/substantia innominata. Brain Res. 1991 Feb 22; 542(1):123-31.
    View in: PubMed
    Score: 0.077
  37. GABAergic and enkephalinergic regulation of locomotion in the ventral pallidum: involvement of the mesolimbic dopamine system. Adv Exp Med Biol. 1991; 295:315-26.
    View in: PubMed
    Score: 0.076
  38. Effect of acute and daily neurotensin and enkephalin treatments on extracellular dopamine in the nucleus accumbens. J Neurosci. 1990 Sep; 10(9):2940-9.
    View in: PubMed
    Score: 0.074
  39. Effect of microinjections of apamin into the A10 dopamine region of rats: a behavioral and neurochemical analysis. J Pharmacol Exp Ther. 1990 Aug; 254(2):711-9.
    View in: PubMed
    Score: 0.074
  40. Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists. J Pharmacol Exp Ther. 1990 May; 253(2):858-66.
    View in: PubMed
    Score: 0.073
  41. Neuroscience: Lack of inhibition leads to abuse. Nature. 2010 Feb 11; 463(7282):743-4.
    View in: PubMed
    Score: 0.072
  42. Sensitization to cocaine produced by injection of pertussis toxin into the A10 dopamine region. NIDA Res Monogr. 1990; 105:545-6.
    View in: PubMed
    Score: 0.071
  43. Effect of acute and daily cocaine treatment on extracellular dopamine in the nucleus accumbens. Synapse. 1990; 5(1):48-58.
    View in: PubMed
    Score: 0.071
  44. Regulation of the mesocorticolimbic dopamine system by glutamic acid receptor subtypes. J Pharmacol Exp Ther. 1989 Oct; 251(1):378-87.
    View in: PubMed
    Score: 0.070
  45. Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J Pharmacol Exp Ther. 2009 Nov; 331(2):555-62.
    View in: PubMed
    Score: 0.069
  46. Autoradiographic localization of mu-opioid and neurotensin receptors within the mesolimbic dopamine system. Brain Res. 1989 May 29; 488(1-2):311-27.
    View in: PubMed
    Score: 0.068
  47. Somatodendritic release of endogenous dopamine: in vivo dialysis in the A10 dopamine region. Neurosci Lett. 1989 May 22; 100(1-3):215-20.
    View in: PubMed
    Score: 0.068
  48. Perspective: the manifest destiny of cocaine research. Neuropsychopharmacology. 2009 Apr; 34(5):1089-90.
    View in: PubMed
    Score: 0.067
  49. Confused about NMDA and addiction? Targeted knockouts provide answers and new questions. Neuron. 2008 Aug 14; 59(3):353-5.
    View in: PubMed
    Score: 0.064
  50. Effects of daily cocaine and morphine treatment on somatodendritic and terminal field dopamine release. J Neurochem. 1988 May; 50(5):1498-504.
    View in: PubMed
    Score: 0.063
  51. Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Br J Pharmacol. 2008 May; 154(2):327-42.
    View in: PubMed
    Score: 0.063
  52. Enkephalin modulation of A10 dopamine neurons: a role in dopamine sensitization. Ann N Y Acad Sci. 1988; 537:405-14.
    View in: PubMed
    Score: 0.062
  53. Behavioral cross-sensitization between cocaine and enkephalin in the A10 dopamine region. Behav Brain Res. 1988 Jan; 27(1):87-91.
    View in: PubMed
    Score: 0.062
  54. Microdialysis and the neurochemistry of addiction. Pharmacol Biochem Behav. 2008 Aug; 90(2):261-72.
    View in: PubMed
    Score: 0.060
  55. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology. 2008 Jan; 33(1):166-80.
    View in: PubMed
    Score: 0.060
  56. Neurochemical and behavioral effects of corticotropin-releasing factor in the ventral tegmental area of the rat. J Pharmacol Exp Ther. 1987 Sep; 242(3):757-63.
    View in: PubMed
    Score: 0.060
  57. Enkephalin release into the ventral tegmental area in response to stress: modulation of mesocorticolimbic dopamine. Brain Res. 1987 Jun 30; 414(2):339-48.
    View in: PubMed
    Score: 0.060
  58. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. J Pharmacol Exp Ther. 1987 Apr; 241(1):328-37.
    View in: PubMed
    Score: 0.059
  59. Sensitization to repeated morphine injection in the rat: possible involvement of A10 dopamine neurons. J Pharmacol Exp Ther. 1987 Apr; 241(1):204-12.
    View in: PubMed
    Score: 0.059
  60. Neurobiology of cocaine addiction: implications for new pharmacotherapy. Am J Addict. 2007 Mar-Apr; 16(2):71-8.
    View in: PubMed
    Score: 0.058
  61. Interaction between thyrotropin-releasing hormone and the mesolimbic dopamine system. Neuropharmacology. 1987 Jan; 26(1):33-8.
    View in: PubMed
    Score: 0.058
  62. Nrf2 gene deletion fails to alter psychostimulant-induced behavior or neurotoxicity. Brain Res. 2007 Jan 05; 1127(1):26-35.
    View in: PubMed
    Score: 0.057
  63. Endogenous enkephalin modulation of dopamine neurons in ventral tegmental area. Am J Physiol. 1986 Aug; 251(2 Pt 2):R243-9.
    View in: PubMed
    Score: 0.056
  64. Homer isoforms differentially regulate cocaine-induced neuroplasticity. Neuropsychopharmacology. 2006 Apr; 31(4):768-77.
    View in: PubMed
    Score: 0.055
  65. Behavioral and neurochemical effect of daily injection with neurotensin into the ventral tegmental area. Brain Res. 1985 Dec 09; 358(1-2):70-6.
    View in: PubMed
    Score: 0.054
  66. Sensitization to repeated enkephalin administration into the ventral tegmental area of the rat. II. Involvement of the mesolimbic dopamine system. J Pharmacol Exp Ther. 1985 Nov; 235(2):544-50.
    View in: PubMed
    Score: 0.053
  67. Mesolimbic dopamine lesions produce an augmented behavioral response to enkephalin. Neuropharmacology. 1985 Oct; 24(10):931-6.
    View in: PubMed
    Score: 0.053
  68. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry. 2005 Aug; 162(8):1403-13.
    View in: PubMed
    Score: 0.052
  69. Activation of orbital and medial prefrontal cortex by methylphenidate in cocaine-addicted subjects but not in controls: relevance to addiction. J Neurosci. 2005 Apr 13; 25(15):3932-9.
    View in: PubMed
    Score: 0.051
  70. A catecholaminergic projection from the ventral tegmental area to the diagonal band of Broca: modulation by neurotensin. Brain Res. 1985 Feb 11; 326(2):229-38.
    View in: PubMed
    Score: 0.051
  71. Dopamine microinjection into the nucleus accumbens: correlation between metabolism and behavior. Biochem Pharmacol. 1985 Jan 15; 34(2):284-6.
    View in: PubMed
    Score: 0.050
  72. Interactions between neuropeptides and dopamine neurons in the ventromedial mesencephalon. Neurosci Biobehav Rev. 1985; 9(4):573-87.
    View in: PubMed
    Score: 0.050
  73. Substance P modulation of the mesolimbic dopamine system. Prog Clin Biol Res. 1985; 192:403-8.
    View in: PubMed
    Score: 0.050
  74. Dissociable roles for the dorsal and median raph? in the facilitatory effect of 5-HT1A receptor stimulation upon cocaine-induced locomotion and sensitization. Neuropsychopharmacology. 2004 Sep; 29(9):1675-87.
    View in: PubMed
    Score: 0.049
  75. Substance P modulation of dopamine in the nucleus accumbens. Neurosci Lett. 1984 Jul 13; 48(1):55-9.
    View in: PubMed
    Score: 0.049
  76. Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J Neurosci. 2004 Feb 18; 24(7):1551-60.
    View in: PubMed
    Score: 0.047
  77. Choose to study choice in addiction. Am J Psychiatry. 2004 Feb; 161(2):193-4.
    View in: PubMed
    Score: 0.047
  78. Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. J Pharmacol Exp Ther. 1983 Oct; 227(1):229-37.
    View in: PubMed
    Score: 0.046
  79. GABA transmission in the nucleus accumbens is altered after withdrawal from repeated cocaine. J Neurosci. 2003 Apr 15; 23(8):3498-505.
    View in: PubMed
    Score: 0.045
  80. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci. 2003 Apr 15; 23(8):3531-7.
    View in: PubMed
    Score: 0.045
  81. The temporal sequence of changes in gene expression by drugs of abuse. Methods Mol Med. 2003; 79:3-11.
    View in: PubMed
    Score: 0.044
  82. The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci. 2001 Nov 01; 21(21):8655-63.
    View in: PubMed
    Score: 0.040
  83. Drug addiction: to the cortex.and beyond! Am J Psychiatry. 2001 Mar; 158(3):349-50.
    View in: PubMed
    Score: 0.038
  84. Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci. 2000 Aug 01; 20(15):RC89.
    View in: PubMed
    Score: 0.037
  85. Interrupted expression of NAC-1 augments the behavioral responses to cocaine. Synapse. 1999 Aug; 33(2):153-9.
    View in: PubMed
    Score: 0.034
  86. Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine. J Pharmacol Exp Ther. 1998 Sep; 286(3):1171-6.
    View in: PubMed
    Score: 0.032
  87. MDMA elicits behavioral and neurochemical sensitization in rats. Neuropsychopharmacology. 1998 Jun; 18(6):469-79.
    View in: PubMed
    Score: 0.032
  88. Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend. 1998 Jun-Jul; 51(1-2):141-53.
    View in: PubMed
    Score: 0.032
  89. The effects of local application of ethanol in the n. accumbens on dopamine overflow and clearance. Alcohol. 1997 Sep-Oct; 14(5):485-92.
    View in: PubMed
    Score: 0.030
  90. Repeated daily cocaine alters subsequent cocaine-induced increase of extracellular dopamine in the medial prefrontal cortex. J Pharmacol Exp Ther. 1997 Apr; 281(1):54-61.
    View in: PubMed
    Score: 0.029
  91. beta-adrenergic antagonism alters the behavioral and neurochemical responses to cocaine. Neuropsychopharmacology. 1996 Mar; 14(3):195-204.
    View in: PubMed
    Score: 0.027
  92. Sensitization to cocaine and dopamine autoreceptor subsensitivity in the nucleus accumbens. Synapse. 1995 May; 20(1):33-6.
    View in: PubMed
    Score: 0.026
  93. The role of mesoaccumbens--pallidal circuitry in novelty-induced behavioral activation. Neuroscience. 1995 Feb; 64(3):587-97.
    View in: PubMed
    Score: 0.025
  94. Behavioral and neurochemical sensitization following cocaine self-administration. Psychopharmacology (Berl). 1994 Jun; 115(1-2):265-72.
    View in: PubMed
    Score: 0.024
  95. Behavioral and neurochemical studies of opioid effects in the pedunculopontine nucleus and mediodorsal thalamus. J Pharmacol Exp Ther. 1994 Apr; 269(1):437-48.
    View in: PubMed
    Score: 0.024
  96. Effect of inhibiting enkephalin catabolism in the VTA on motor activity and extracellular dopamine. Brain Res. 1992 Dec 25; 599(2):209-14.
    View in: PubMed
    Score: 0.022
  97. Topography and functional role of dopaminergic projections from the ventral mesencephalic tegmentum to the ventral pallidum. Neuroscience. 1992 Sep; 50(2):371-86.
    View in: PubMed
    Score: 0.021
  98. Cellular mechanisms of behavioral sensitization to drugs of abuse. Ann N Y Acad Sci. 1992 Jun 28; 654:128-35.
    View in: PubMed
    Score: 0.021
  99. Apomorphine decreases extracellular GABA in the ventral pallidum of rats with 6-OHDA lesions in the nucleus accumbens. Brain Res. 1992 Apr 17; 577(2):306-11.
    View in: PubMed
    Score: 0.021
  100. The role of the nucleus accumbens in sensitization to drugs of abuse. Prog Neuropsychopharmacol Biol Psychiatry. 1992 Mar; 16(2):237-46.
    View in: PubMed
    Score: 0.021
  101. Neural substrate of sensitization to psychostimulants. Clin Neuropharmacol. 1992; 15 Suppl 1 Pt A:648A-649A.
    View in: PubMed
    Score: 0.020
  102. Neurotensin binding to dopamine. J Neurochem. 1990 Apr; 54(4):1321-8.
    View in: PubMed
    Score: 0.018
  103. Blockade of enkephalinergic and GABAergic mediated locomotion in the nucleus accumbens by muscimol in the ventral pallidum. Jpn J Pharmacol. 1989 Aug; 50(4):487-90.
    View in: PubMed
    Score: 0.017
  104. Similar effects of daily cocaine and stress on mesocorticolimbic dopamine neurotransmission in the rat. Biol Psychiatry. 1989 Apr 01; 25(7):913-28.
    View in: PubMed
    Score: 0.017
  105. Behavioral and neurochemical effects of acute and daily cocaine administration in rats. J Pharmacol Exp Ther. 1988 May; 245(2):485-92.
    View in: PubMed
    Score: 0.016
  106. The effect of cholinergic stimulation in the nucleus accumbens on locomotor behavior. Brain Res. 1988 Feb 16; 441(1-2):209-14.
    View in: PubMed
    Score: 0.016
  107. Requirement for the POZ/BTB protein NAC1 in acute but not chronic psychomotor stimulant response. Behav Brain Res. 2008 Feb 11; 187(1):48-55.
    View in: PubMed
    Score: 0.015
  108. Sexual refractoriness and locomotion effects on brain monoamines in the male rat. Physiol Behav. 1987; 41(6):563-9.
    View in: PubMed
    Score: 0.014
  109. Neuromedin N mimics the actions of neurotensin in the ventral tegmental area but not in the nucleus accumbens. J Pharmacol Exp Ther. 1986 Sep; 238(3):1126-31.
    View in: PubMed
    Score: 0.014
  110. Cross-sensitization between foot shock stress and enkephalin-induced motor activity. Biol Psychiatry. 1986 Aug; 21(10):939-50.
    View in: PubMed
    Score: 0.014
  111. Substance K and substance P in the ventral tegmental area. Neurosci Lett. 1985 Jun 24; 57(3):241-6.
    View in: PubMed
    Score: 0.013
  112. Microinjection of neurotensin into the ventral tegmental area produces hypothermia: evaluation of dopaminergic mediation. Brain Res. 1985 Feb 11; 326(2):219-27.
    View in: PubMed
    Score: 0.013
  113. Bombesin-induced locomotor hyperactivity: evaluation of the involvement of the mesolimbic dopamine system. Brain Res. 1984 Jun 25; 304(2):377-82.
    View in: PubMed
    Score: 0.012
  114. Influence of cholecystokinin on central monoaminergic pathways. Regul Pept. 1983 May; 6(2):99-109.
    View in: PubMed
    Score: 0.011
  115. Interactions of neurotensin with brain dopamine systems. Ann N Y Acad Sci. 1982; 400:330-44.
    View in: PubMed
    Score: 0.010
  116. Neuroanatomical sites of action of neurotensin. Ann N Y Acad Sci. 1982; 400:307-18.
    View in: PubMed
    Score: 0.010
  117. Substance K and substance P differentially modulate mesolimbic and mesocortical systems. Peptides. 1985; 6 Suppl 2:113-22.
    View in: PubMed
    Score: 0.003
  118. Possible involvement of serotonergic neurotransmission in neurotensin but not morphine analgesia. Brain Res. 1984 Sep 17; 310(1):35-41.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.